<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34156763</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS-FTD spectrum.</ArticleTitle><Pagination><StartPage>1576</StartPage><EndPage>1591</EndPage><MedlinePgn>1576-1591</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51363</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The aims of this study were to (i) explore psychotic experiences across the entire amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) spectrum from a clinical and genetic perspective, (ii) determine the rate of abnormal perceptual experiences across the five sensory modalities and (iii) explore the neurobiological factors that lead to psychosis vulnerability in ALS-FTD.</AbstractText><AbstractText Label="METHODS">In a prospective case-controlled study design, 100 participants were enrolled including ALS (n&#xa0;=&#xa0;37, 24% satisfied criteria for ALS-Plus), ALS-FTD (n&#xa0;=&#xa0;11), bvFTD (n&#xa0;=&#xa0;27) and healthy controls (n&#xa0;=&#xa0;25). Psychotic experiences, perceptual abnormalities and psychosocial factors were determined by means of the clinical interview and carer and patient reports. Voxel-based morphometry analyses determined atrophy patterns in patients experiencing psychosis-like experiences and other perceptual abnormalities.</AbstractText><AbstractText Label="RESULTS">The rates of psychotic experiences and abnormalities of perception in each sensory modality were high across the entire ALS-FTD continuum. The rate was highest in those with C9orf72 expansions. Rates were also high in patients with pure ALS including psychosis measured by carer-based reports (18%) and self-report measures of psychotic-like experiences (21%). In an ENTER regression model, social anxiety and ACE-III scores were the best predictors of psychosis proneness, accounting for 44% of the score variance. Psychosis-like experiences and perceptual abnormalities were associated with a predominantly frontal and temporal pattern of atrophy that extended to the cerebellum and centred on the anterior thalamus.</AbstractText><AbstractText Label="INTERPRETATION">The model for psychosis proneness in ALS-FTD likely includes complex interactions between cognitive, social and neurobiological factors that determine vulnerability to psychosis and that may have relevance for individualised patient management.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Devenney</LastName><ForeName>Emma M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0001-6140-0452</Identifier><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Health Translational Research Collective, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Sicong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Health Translational Research Collective, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caga</LastName><ForeName>Jashelle</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Health Translational Research Collective, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Rebekah M</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0001-6996-8317</Identifier><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramsey</LastName><ForeName>Eleanor</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoing</LastName><ForeName>Margie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwok</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Health School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halliday</LastName><ForeName>Glenda M</ForeName><Initials>GM</Initials><Identifier Source="ORCID">0000-0003-0422-8398</Identifier><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Health School of Medical Sciences, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piguet</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Science, School of Psychology, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian Research Council Centre of Excellence in Cognition and its Disorders, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodges</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiernan</LastName><ForeName>Matthew C</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0001-9054-026X</Identifier><AffiliationInfo><Affiliation>Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Health Translational Research Collective, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010468" MajorTopicYN="N">Perceptual Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011618" MajorTopicYN="N">Psychotic Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34156763</ArticleId><ArticleId IdType="pmc">PMC8351398</ArticleId><ArticleId IdType="doi">10.1002/acn3.51363</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Devenney E, Vucic S, Hodges JR, Kiernan MC. Motor neuron disease&#x2010;frontotemporal dementia: a clinical continuum. Expert Rev Neurother 2015;15:509&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pubmed">25865485</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, Kiernan MC, Vucic S, Hodges JR. Motor neuron dysfunction in frontotemporal dementia. Brain 2011;134(Pt 9):2582&#x2013;2594.</Citation><ArticleIdList><ArticleId IdType="pubmed">21840887</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et&#xa0;al. A Hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21&#x2010;linked ALS&#x2010;FTD. Neuron 2011;72:257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus&#x2010;Hernandez M, Mackenzie IR, Boeve BF, et&#xa0;al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p&#x2010;linked FTD and ALS. Neuron 2011;72:245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney E, Hornberger M, Irish M, et&#xa0;al. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol 2014;71:331&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">24445580</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez MF, Shapira JS, Woods RJ, et&#xa0;al. Psychotic symptoms in frontotemporal dementia: prevalence and review. Dement Geriatr Cogn Disord 2008;25:206&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">18204254</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney EM, Landin&#x2010;Romero R, Irish M, et&#xa0;al. The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion. Neuroimage Clin 2017;13:439&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5233794</ArticleId><ArticleId IdType="pubmed">28116236</ArticleId></ArticleIdList></Reference><Reference><Citation>Association AP . Diagnostic and statistical manual of mental disorders: DSM&#x2010;5. Washington, DC: American Psychiatric Association, 2013.</Citation></Reference><Reference><Citation>Organization WH . The ICD&#x2010;10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Wkly Epidemiol Rec 1992;67:227.</Citation></Reference><Reference><Citation>Hall D, Finger EC. Psychotic symptoms in frontotemporal dementia. Curr Neurol Neurosci Rep 2015;15:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26008815</ArticleId></ArticleIdList></Reference><Reference><Citation>Downey LE, Fletcher PD, Golden HL, et&#xa0;al. Altered body schema processing in frontotemporal dementia with C9ORF72 mutations. J Neurol Neurosurg Psychiatry 2014;85:1016&#x2013;1023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4145454</ArticleId><ArticleId IdType="pubmed">24521566</ArticleId></ArticleIdList></Reference><Reference><Citation>Downey LE, Mahoney CJ, Rossor MN, et&#xa0;al. Impaired self&#x2010;other differentiation in frontotemporal dementia due to the C9ORF72 expansion. Alzheimer's Res Ther 2012;4:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3580399</ArticleId><ArticleId IdType="pubmed">23016833</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung AR, McGorry PD. The prodromal phase of first&#x2010;episode psychosis: past and current conceptualizations. Schizophr Bull 1996;22:353&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">8782291</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman LJ, Edell WS, Chapman JP. Physical anhedonia, perceptual aberration, and psychosis proneness. Schizophr Bull 1980;6:639.</Citation><ArticleIdList><ArticleId IdType="pubmed">7444395</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman LJ, Chapman JP. The search for symptoms predictive of schizophrenia. Schizophr Bull 1987;13:497&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">3629203</ArticleId></ArticleIdList></Reference><Reference><Citation>Claridge G. Single indicator of risk for schizophrenia: probable fact or likely myth? Schizophr Bull 1994;20:151&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">8197412</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuldberg D. Six subclinical spectrum traits in normal creativity. Creat Res J 2001;13:5&#x2013;16.</Citation></Reference><Reference><Citation>van Os J, Kenis G, Rutten BP. The environment and schizophrenia. Nature 2010;468:203&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pubmed">21068828</ArticleId></ArticleIdList></Reference><Reference><Citation>Glahn DC, Laird AR, Ellison&#x2010;Wright I, et&#xa0;al. Meta&#x2010;analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiat 2008;64:774&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5441233</ArticleId><ArticleId IdType="pubmed">18486104</ArticleId></ArticleIdList></Reference><Reference><Citation>Fusar&#x2010;Poli P, Radua J, McGuire P, Borgwardt S. Neuroanatomical maps of psychosis onset: voxel&#x2010;wise meta&#x2010;analysis of antipsychotic&#x2010;naive VBM studies. Schizophr Bull 2011;38:1297&#x2013;1307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3494061</ArticleId><ArticleId IdType="pubmed">22080494</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Greicius MD, Gennatas ED, et&#xa0;al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer&#x2019;s disease. Brain 2010;133:1352&#x2013;1367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2912696</ArticleId><ArticleId IdType="pubmed">20410145</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeter ML, Raczka K, Neumann J, Von Cramon DY. Neural networks in frontotemporal dementia&#x2014;a meta&#x2010;analysis. Neurobiol Aging 2008;29:418&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pubmed">17140704</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SE, Khazenzon AM, Trujillo AJ, et&#xa0;al. Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion. Brain 2014;137:3047&#x2013;3060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4208465</ArticleId><ArticleId IdType="pubmed">25273996</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney CJ, Beck J, Rohrer JD, et&#xa0;al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features Brain 2012;135:736&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286330</ArticleId><ArticleId IdType="pubmed">22366791</ArticleId></ArticleIdList></Reference><Reference><Citation>Ettinger U, Chitnis XA, Kumari V, et&#xa0;al. Magnetic resonance imaging of the thalamus in first&#x2010;episode psychosis. Am J Psychiatry 2001;158:116&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">11136642</ArticleId></ArticleIdList></Reference><Reference><Citation>Talvik M, Nordstr&#xf6;m A&#x2010;L, Olsson H, et&#xa0;al. Decreased thalamic D2/D3 receptor binding in drug&#x2010;naive patients with schizophrenia: a PET study with [11C] FLB 457. Int J Neuropsychopharmacol 2003;6:361&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pubmed">14604451</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang DJ, Khorram B, Goghari VM, et&#xa0;al. Reduced anterior internal capsule and thalamic volumes in first&#x2010;episode psychosis. Schizophr Res 2006;87:89&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">16793239</ArticleId></ArticleIdList></Reference><Reference><Citation>Marenco S, Stein JL, Savostyanova AA, et&#xa0;al. Investigation of anatomical thalamo&#x2010;cortical connectivity and FMRI activation in schizophrenia. Neuropsychopharmacology 2012;37:499&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3242311</ArticleId><ArticleId IdType="pubmed">21956440</ArticleId></ArticleIdList></Reference><Reference><Citation>Danos P, Baumann B, Kr&#xe4;mer A, et&#xa0;al. Volumes of association thalamic nuclei in schizophrenia: a postmortem study. Schizophr Res 2003;60:141&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">12591578</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang AS, Rogers BP, Sheffield JM, et&#xa0;al. Thalamic nuclei volumes in psychotic disorders and in youths with psychosis spectrum symptoms. Am J Psychiatry 2020;177:1159&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7708443</ArticleId><ArticleId IdType="pubmed">32911995</ArticleId></ArticleIdList></Reference><Reference><Citation>Anticevic A, Yang G, Savic A, et&#xa0;al. Mediodorsal and visual thalamic connectivity differ in schizophrenia and bipolar disorder with and without psychosis history. Schizophr Bull 2014;40:1227&#x2013;1243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4193728</ArticleId><ArticleId IdType="pubmed">25031221</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmahmann JD. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsy Clin Neurosci 2004;16:367&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">15377747</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshi E, Tremblay L, F&#xe9;ger J, et&#xa0;al. The cerebellum communicates with the basal ganglia. Nat Neurosci 2005;8:1491&#x2013;1493.</Citation><ArticleIdList><ArticleId IdType="pubmed">16205719</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, et&#xa0;al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134(Pt 9):2456&#x2013;2477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2000;1:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Al&#x2010;Chalabi A, Baker MR, et&#xa0;al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol 2020;131:1975&#x2013;1978.</Citation><ArticleIdList><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Talbot K, et&#xa0;al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat Rev Neurol 2020;17:1&#x2013;5.</Citation></Reference><Reference><Citation>Hsieh S, Schubert S, Hoon C, et&#xa0;al. Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord 2013;36:242&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">23949210</ArticleId></ArticleIdList></Reference><Reference><Citation>Wear HJ, Wedderburn CJ, Mioshi E, et&#xa0;al. The Cambridge behavioural inventory revised. Dement Neuropsychol 2008;2:102&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5619578</ArticleId><ArticleId IdType="pubmed">29213551</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et&#xa0;al. Amyotrophic lateral sclerosis&#x2010;frontotemporal spectrum disorder (ALS&#x2010;FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 2017;18:153&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Grace GM, Freedman M, et&#xa0;al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:131&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">19462523</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson&#x2010;Stone C, Hallupp M, Bartley L, et&#xa0;al. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts. Neurology 2012;79:995&#x2013;1001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3430710</ArticleId><ArticleId IdType="pubmed">22875086</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofield EC, Halliday GM, Kwok J, et&#xa0;al. Low serum progranulin predicts the presence of mutations: a prospective study. J Alzheimers Dis 2010;22:981&#x2013;984.</Citation><ArticleIdList><ArticleId IdType="pubmed">20858962</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanford PM, Shepherd CE, Halliday GM, et&#xa0;al. Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. Brain 2003;126:814&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pubmed">12615641</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell V, Halligan PW, Ellis HD. The Cardiff Anomalous Perceptions Scale (CAPS): a new validated measure of anomalous perceptual experience. Schizophr Bull 2006;32:366&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2632213</ArticleId><ArticleId IdType="pubmed">16237200</ArticleId></ArticleIdList></Reference><Reference><Citation>Antony MM, Bieling PJ, Cox BJ, et&#xa0;al. Psychometric properties of the 42&#x2010;item and 21&#x2010;item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample. Psychol Assess 1998;10:176.</Citation></Reference><Reference><Citation>Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM&#x2010;III&#x2010;R criteria. Schizophr Bull 1991;17:555.</Citation><ArticleIdList><ArticleId IdType="pubmed">1805349</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation&#x2010;maximization algorithm. IEEE Trans Med Imaging 2001;20:45&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">11293691</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">11516708</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen&#x2010;Berg H, Behrens TEJ, Sillery E, et&#xa0;al. Functional&#x2010;anatomical validation and individual variation of diffusion tractography&#x2010;based segmentation of the human thalamus. Cereb Cortex 2005;15:31&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">15238447</ArticleId></ArticleIdList></Reference><Reference><Citation>Gellersen HM, Guo CC, O&#x2019;Callaghan C, et&#xa0;al. Cerebellar atrophy in neurodegeneration&#x2014;a meta&#x2010;analysis. J Neurol Neurosurg Psychiatry 2017;88:780&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pubmed">28501823</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Fifita JA, Vucic S, et&#xa0;al. Pathophysiological insights into ALS with C9ORF72 expansions. J Neurol Neurosurg Psychiatry 2013;84:931&#x2013;935:jnnp&#x2010;2012&#x2010;304529.</Citation><ArticleIdList><ArticleId IdType="pubmed">23463871</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden JS, Harris J, Richardson A, et&#xa0;al. Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:172&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">23421625</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, Lillo P, Yew B, et&#xa0;al. Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes. Neurology 2013;80:1117&#x2013;1123.</Citation><ArticleIdList><ArticleId IdType="pubmed">23427327</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, Caga J, Lillo P, et&#xa0;al. Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival. Neurology 2014;82:149&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">24336140</ArticleId></ArticleIdList></Reference><Reference><Citation>Garety PA, Kuipers E, Fowler D, et&#xa0;al. A cognitive model of the positive symptoms of psychosis. Psychol Med 2001;31:189&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">11232907</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hooren S, Versmissen D, Janssen I, et&#xa0;al. Social cognition and neurocognition as independent domains in psychosis. Schizophr Res 2008;103:257&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">18434094</ArticleId></ArticleIdList></Reference><Reference><Citation>Atassi N, Cook A, Pineda CM, et&#xa0;al. Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011;12:109&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3155886</ArticleId><ArticleId IdType="pubmed">21091399</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos E, Mariosa D, Ingre C, et&#xa0;al. Depression in amyotrophic lateral sclerosis. Neurology 2016;86:2271&#x2013;2277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4909561</ArticleId><ArticleId IdType="pubmed">27164661</ArticleId></ArticleIdList></Reference><Reference><Citation>Caga J, Ramsey E, Hogden A, et&#xa0;al. A longer diagnostic interval is a risk for depression in amyotrophic lateral sclerosis. Palliat Supportive Care 2015;13:1019&#x2013;1024.</Citation><ArticleIdList><ArticleId IdType="pubmed">25137152</ArticleId></ArticleIdList></Reference><Reference><Citation>Broome MR, Woolley JB, Tabraham P, et&#xa0;al. What causes the onset of psychosis? Schizophr Res 2005;79:23&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">16198238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamura Y, Dyck PJ, Shimono M, et&#xa0;al. Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 1981;40:667&#x2013;675.</Citation><ArticleIdList><ArticleId IdType="pubmed">7299423</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugdahl K, Fuglsang&#x2010;Frederiksen A, de Carvalho M, et&#xa0;al. Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study. J Neurol Neurosurg Psychiatry 2007;78:746&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2117695</ArticleId><ArticleId IdType="pubmed">17575020</ArticleId></ArticleIdList></Reference><Reference><Citation>Weil RS, Schrag AE, Warren JD, et&#xa0;al. Visual dysfunction in Parkinson&#x2019;s disease. Brain 2016;139:2827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5091042</ArticleId><ArticleId IdType="pubmed">27412389</ArticleId></ArticleIdList></Reference><Reference><Citation>Diederich NJ, Goetz CG, Raman R, et&#xa0;al. Poor visual discrimination and visual hallucinations in Parkinson's disease. Clin Neuropharmacol 1998;21:289&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">9789709</ArticleId></ArticleIdList></Reference><Reference><Citation>Shine JM, O&#x2019;Callaghan C, Halliday GM, Lewis SJ. Tricks of the mind: visual hallucinations as disorders of attention. Prog Neurogibol 2014;116:58&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">24525149</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Devenney EM, Irish M, et&#xa0;al. Neuronal network disintegration: common pathways linking neurodegenerative diseases. J Neurol Neurosurg Psychiatry 2016;87:1234&#x2013;1241:jnnp&#x2010;2014&#x2010;308350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5099318</ArticleId><ArticleId IdType="pubmed">27172939</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler PD, Javitt DC. Early&#x2010;stage visual processing deficits in schizophrenia. Curr Opin Psychiatry 2005;18:151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1994776</ArticleId><ArticleId IdType="pubmed">16639168</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler PD, Zemon V, Schechter I, et&#xa0;al. Early&#x2010;stage visual processing and cortical amplification deficits in schizophrenia. Arch Gen Psychiatry 2005;62:495&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1298183</ArticleId><ArticleId IdType="pubmed">15867102</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadenhead KS, Serper Y, Braff DL. Transient versus sustained visual channels in the visual backward masking deficits of schizophrenia patients. Biol Psychiat 1998;43:132&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">9474445</ArticleId></ArticleIdList></Reference><Reference><Citation>Hailstone JC, Ridgway GR, Bartlett JW, et&#xa0;al. Voice processing in dementia: a neuropsychological and neuroanatomical analysis. Brain 2011;134:2535&#x2013;2547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170540</ArticleId><ArticleId IdType="pubmed">21908871</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher PD, Downey L, Witoonpanich P, Warren J. The brain basis of musicophilia: evidence from frontotemporal lobar degeneration. Front Psychol 2013;4:347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3689257</ArticleId><ArticleId IdType="pubmed">23801975</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar R, Mahoney CJ, Buckley AH, Warren JD. Flavour identification in frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 2013;84:88&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3534254</ArticleId><ArticleId IdType="pubmed">23138765</ArticleId></ArticleIdList></Reference><Reference><Citation>Luzzi S, Snowden JS, Neary D, et&#xa0;al. Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia 2007;45:1823&#x2013;1831.</Citation><ArticleIdList><ArticleId IdType="pubmed">17270222</ArticleId></ArticleIdList></Reference><Reference><Citation>Rami L, Loy CT, Hailstone J, Warren JD. Odour identification in frontotemporal lobar degeneration. J Neurol 2007;254:431&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2567055</ArticleId><ArticleId IdType="pubmed">17380245</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkes C, Shephard B, Geddes J, et&#xa0;al. Olfactory disorder in motor neuron disease. Exp Neurol 1998;150:248&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">9527894</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald C, Bullmore ED, Sham P, et&#xa0;al. Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study. Br J Psychiatry 2005;186:369&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pubmed">15863740</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta M, Gordon E, Cardoso MJ, et&#xa0;al. Thalamic atrophy in frontotemporal dementia &#x2010; not just a C9orf72 problem. Neuroimage Clin 2018;18:675&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5988457</ArticleId><ArticleId IdType="pubmed">29876259</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu S, Menke RAL, Talbot K, et&#xa0;al. Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2018;89:1250&#x2013;1258.</Citation><ArticleIdList><ArticleId IdType="pubmed">30049750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocchetta M, Iglesias JE, Neason M, et&#xa0;al. Thalamic nuclei in frontotemporal dementia: mediodorsal nucleus involvement is universal but pulvinar atrophy is unique to C9orf72. Hum Brain Mapp 2020;41:1006&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267940</ArticleId><ArticleId IdType="pubmed">31696638</ArticleId></ArticleIdList></Reference><Reference><Citation>Byne W, Hazlett EA, Buchsbaum MS, Kemether E. The thalamus and schizophrenia: current status of research. Acta Neuropathol 2009;117:347.</Citation><ArticleIdList><ArticleId IdType="pubmed">18604544</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nkle M, Waldvogel H, Faull R. The distribution of calbindin, calretinin and parvalbumin immunoreactivity in the human thalamus. J Chem Neuroanat 2000;19:155&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">10989260</ArticleId></ArticleIdList></Reference><Reference><Citation>Danos P, Baumann B, Bernstein H&#x2010;G, et&#xa0;al. Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin&#x2010;immunoreactive thalamocortical projection neurons. Psychiatry Res 1998;82:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">9645546</ArticleId></ArticleIdList></Reference><Reference><Citation>Byne W, Kidkardnee S, Tatusov A, et&#xa0;al. Schizophrenia&#x2010;associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus. Schizophr Res 2006;85:245&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">16730162</ArticleId></ArticleIdList></Reference><Reference><Citation>Shergill SS, Brammer MJ, Williams SC, et&#xa0;al. Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry 2000;57:1033&#x2013;1038.</Citation><ArticleIdList><ArticleId IdType="pubmed">11074868</ArticleId></ArticleIdList></Reference><Reference><Citation>Barta PE, Pearlson GD, Powers RE, et&#xa0;al. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 1990;147:1457&#x2013;1462.</Citation><ArticleIdList><ArticleId IdType="pubmed">2221156</ArticleId></ArticleIdList></Reference><Reference><Citation>Modinos G, Costafreda SG, van Tol M&#x2010;J, et&#xa0;al. Neuroanatomy of auditory verbal hallucinations in schizophrenia: a quantitative meta&#x2010;analysis of voxel&#x2010;based morphometry studies. Cortex 2013;49:1046&#x2013;1055.</Citation><ArticleIdList><ArticleId IdType="pubmed">22370252</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen P, Lar&#xf8;i F, McGuire PK, Aleman A. The hallucinating brain: a review of structural and functional neuroimaging studies of hallucinations. Neurosci Biobehav Rev 2008;32:175&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pubmed">17884165</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen P, Modinos G, Hubl D, et&#xa0;al. Neuroimaging auditory hallucinations in schizophrenia: from neuroanatomy to neurochemistry and beyond. Schizophr Bull 2012;38:695&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3406523</ArticleId><ArticleId IdType="pubmed">22535906</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>